Clinical Chemistry

Liquid Chromatography Mass Spectrometry Biomarkers

Development and validation of LC-MS/MS methods for detecting novel disease biomarkers in clinical samples with high specificity and sensitivity.

RESEARCH GAP FRONTIERS

Point-of-Care Testing Microfluidic Devices

Engineering miniaturized diagnostic platforms for rapid on-site clinical analysis with minimal sample volumes and real-time results.

RESEARCH GAP FRONTIERS

Circulating Tumor DNA Detection Methods

Advanced molecular techniques for identifying and quantifying ctDNA in blood for early cancer detection and therapeutic monitoring.

RESEARCH GAP FRONTIERS

Protein Biomarker Discovery Proteomics

High-throughput proteomic approaches to identify disease-specific protein signatures and their clinical diagnostic applications.

RESEARCH GAP FRONTIERS

Immunoassay Multiplexing Platforms

Development of simultaneous multi-analyte detection systems using advanced immunoassay technologies for comprehensive clinical profiling.

RESEARCH GAP FRONTIERS

Therapeutic Drug Monitoring Personalized Medicine

Optimization of drug level monitoring strategies to achieve individualized therapeutic outcomes and reduce adverse effects.

RESEARCH GAP FRONTIERS

Extracellular Vesicle Biomarkers Analysis

Isolation and characterization of exosomes and microvesicles as non-invasive biomarkers for disease diagnosis and prognosis.

RESEARCH GAP FRONTIERS

Metabolomics Signature Disease Diagnosis

Comprehensive metabolite profiling to establish disease-specific metabolic signatures for novel diagnostic and stratification applications.

RESEARCH GAP FRONTIERS

High-Sensitivity Troponin Assay Optimization

Refinement of ultra-sensitive cardiac troponin measurements for improved acute myocardial infarction detection and risk stratification.

Glycosylation Pattern Analysis Diagnostics

Investigation of altered protein glycosylation patterns as biomarkers for cancer, autoimmune, and metabolic disease detection.

Electrochemical Biosensor Development

Creation of label-free electrochemical sensors for direct analyte detection with enhanced sensitivity and reduced assay time.

MicroRNA Profiling Disease Prognosis

Characterization of circulating miRNA signatures as predictive biomarkers for disease progression and treatment response.

Real-Time PCR Viral Load Quantification

Development of rapid molecular quantification methods for infectious disease monitoring and antimicrobial therapy guidance.

Kidney Function Biomarkers CKD Staging

Novel marker discovery beyond creatinine for improved chronic kidney disease classification and progression prediction.

Allergen-Specific IgE Testing Methods

Enhancement of allergic sensitization detection through advanced immunological testing for comprehensive allergen profiling.

Hemoglobin Variant Identification Analysis

High-resolution techniques for detecting and characterizing hemoglobin variants relevant to hemolytic anemia and blood disorders.

Lipoprotein Subclass Distribution Cardiovascular

Advanced lipid profiling methods to characterize lipoprotein particle size and density for improved cardiovascular risk assessment.

Bone Turnover Marker Osteoporosis Assessment

Utilization of collagen degradation and synthesis markers for monitoring bone remodeling and treatment efficacy in skeletal disease.

B-Type Natriuretic Peptide Heart Failure

Optimization of BNP and NT-proBNP measurement for heart failure diagnosis, risk stratification, and disease management.

Immunoglobulin Free Light Chains Multiple Myeloma

Development of rapid free light chain assays for detection and monitoring of plasma cell disorders and light chain disease.

Phosphorylated Tau Protein Neurodegeneration

Sensitive detection of phospho-tau variants in blood as emerging biomarkers for Alzheimer''s disease and tauopathies.

Inflammatory Cytokine Profiling Autoimmunity

Multiplex measurement of pro-inflammatory and regulatory cytokines to characterize immune dysregulation in autoimmune conditions.

Tumor Suppressor Gene Mutation Detection

Molecular techniques for identifying pathogenic variants in tumor suppressors for cancer risk assessment and treatment planning.

Homocysteine Thromboembolic Disease Risk

Investigation of hyperhomocysteinemia as an independent risk factor for cardiovascular and cerebrovascular thrombotic events.

Procalcitonin Bacterial Infection Discrimination

High-sensitivity procalcitonin measurement to distinguish bacterial infections from viral and inflammatory conditions in sepsis evaluation.

Antiphospholipid Antibody Syndrome Diagnosis

Standardized serological testing for lupus anticoagulant and anticardiolipin antibodies in thrombotic and obstetric complications.

Steroid Hormone Metabolite Endocrinology

Quantification of steroid metabolites using tandem mass spectrometry for comprehensive endocrine disorder evaluation and treatment monitoring.

Mycotoxin Detection Food Safety

Development of rapid immunoassay and chromatographic methods for detecting contaminating mycotoxins in clinical and food samples.

Human Papillomavirus Genotyping Cervical Cancer

Molecular identification of high-risk HPV genotypes for improved cervical cancer screening and prevention strategies.

Galectin-3 Heart Failure Fibrosis

Investigation of galectin-3 as a marker of cardiac fibrosis and predictor of outcomes in heart failure and cardiomyopathy.

Fecal Calprotectin Inflammatory Bowel Disease

Non-invasive quantification of neutrophil-derived calprotectin in stool for IBD activity assessment and treatment monitoring.

Tissue Factor Pathway Inhibitor Thrombosis

Measurement of TFPI activity and antigen levels for evaluating anticoagulation status and thrombotic risk assessment.

Chromatin Fragmentation DNA Integrity

Assessment of cell-free DNA degradation patterns and nucleosome profiles as markers of cell death and tissue damage.

Androsterone Metabolite Androgen Excess

Specialized measurement of minor androgen metabolites using advanced chromatography to detect mild hyperandrogenism.

Adiponectin Metabolic Syndrome Insulin Resistance

Quantification of circulating adiponectin levels as a marker of metabolic dysfunction and insulin sensitivity status.

Vitamin D Metabolite Profiling Bone Health

Comprehensive measurement of 25-OH vitamin D, 1,25-diOH vitamin D, and metabolites for skeletal disease assessment.

Amyloid Beta Peptide Oligomerization Dementia

Detection of various amyloid-beta forms and aggregation states in cerebrospinal fluid for Alzheimer''s disease diagnosis.

Soluble RAGE Vascular Inflammation

Measurement of circulating advanced glycation end product receptors as markers of endothelial dysfunction and diabetic complications.

Bacterial Lipopolysaccharide Endotoxemia Detection

Development of sensitive LAL and alternative chromogenic assays for detecting systemic endotoxin in clinical specimens.

Telomerase Activity Cancer Cell Detection

Measurement of telomerase enzyme activity in bodily fluids as a sensitive marker for malignant cell presence and proliferation.

Leptin Ghrelin Appetite Regulation

Quantification of satiety and hunger hormones to investigate metabolic dysregulation in obesity and eating disorders.

Rheumatoid Factor IgM Autoimmunity

High-sensitivity measurement of rheumatoid factor isotypes for improved rheumatoid arthritis diagnosis and prognostic stratification.

Transferrin Saturation Iron Metabolism

Precision measurement of serum iron and iron-binding capacity for hemochromatosis detection and iron overload monitoring.

Matrix Metalloproteinase Activity Tissue Remodeling

Assessment of protease and antiprotease balance through MMP measurement for fibrosis and inflammatory disease characterization.

Complement Activation Marker Detection

Measurement of C3a, C5a, and terminal complement complexes to evaluate complement system activation in immune diseases.

Cystatin C Glomerular Filtration Rate

Development of standardized cystatin C assays as improved filtration markers independent of muscle mass and metabolism.

Substance P Neuropeptide Pain Disorders

Quantification of cerebrospinal fluid substance P as a biomarker for chronic pain syndromes and neuropathic conditions.

Antinuclear Antibody Pattern Recognition

Advanced immunofluorescence and line immunoassay techniques for comprehensive ANA pattern identification in autoimmune screening.

Lactate Dehydrogenase Isoenzyme Tissue Damage

Fractionation of LDH isoenzymes to determine organ-specific injury patterns in myocardial, hepatic, and renal diseases.

D-Dimer Venous Thromboembolism Risk

Optimization of D-dimer assays with improved specificity for VTE exclusion and guidance of anticoagulation therapy.

Phosphoproteomics Signaling Pathway Cancer Biology

Investigation of phosphorylated protein networks to elucidate aberrant signaling cascades driving malignant transformation and therapeutic resistance mechanisms.

Organic Acid Metabolite Mitochondrial Disease

Quantification of urinary and plasma organic acids for diagnosis and monitoring of inherited mitochondrial oxidative metabolism disorders.

Volatile Organic Compound Breath Analysis

Development of GC-MS and electronic nose technologies to detect disease-specific VOC signatures in exhaled breath for non-invasive diagnostics.

Amino Acid Profiling Inborn Errors Metabolism

Tandem mass spectrometry-based amino acid quantification for newborn screening and diagnosis of metabolic disorders affecting amino acid metabolism.

N-Glycan Structure Immunoglobulin Functionality

Analysis of N-linked glycosylation patterns on antibodies to understand immune response efficacy and therapeutic antibody engineering applications.

Serum Free Light Chain Monoclonal Gammopathy

High-sensitivity measurement of circulating immunoglobulin free light chains for detecting and monitoring plasma cell dyscrasias and light chain diseases.

Fasting Glucose Insulin Resistance Biomarkers

Integration of glucose, insulin, and c-peptide measurements with homeostasis model assessment for metabolic dysfunction classification and diabetes risk stratification.

Lipoprotein Lipase Activity Hypertriglyceridemia

Functional assays measuring lipoprotein lipase activity and mass in plasma for diagnosing familial chylomicronemia and severe triglyceride disorders.

Apolipoprotein Isoform Genetic Polymorphism

Characterization of apolipoprotein E, B, and C isoforms and their polymorphisms to predict cardiovascular and neurodegenerative disease susceptibility.

Mycophenolic Acid Metabolite Immunosuppression

High-performance liquid chromatography measurement of mycophenolic acid and its glucuronide metabolite for transplant patient immune monitoring.

Vancomycin Concentration Target Attainment

Individualized vancomycin dosing optimization using area-under-curve and minimum inhibitory concentration calculations for resistant gram-positive infections.

Methotrexate Polyglutamate Accumulation Leukemia

Measurement of intracellular methotrexate polyglutamate metabolites as pharmacodynamic markers predicting treatment response in acute lymphoblastic leukemia.

Immunosuppressant Drug Interaction Pharmacogenomics

Integrated analysis of tacrolimus, cyclosporine, and sirolimus levels with CYP3A genetic variants for personalized transplant immunotherapy.

Cardiac Troponin I High-Sensitivity Detection

Ultra-sensitive immunoassay optimization for cardiac troponin I with femtomolar detection limits enabling early acute myocardial infarction diagnosis.

Myoglobin Skeletal Muscle Injury Biomarker

Rapid myoglobin quantification for distinguishing muscle injury types, rhabdomyolysis severity, and acute kidney injury risk stratification.

Creatine Kinase Isoenzyme Tissue Source

Electrophoretic and immunological separation of CK-BB, CK-MB, and CK-MM isoenzymes for organ-specific injury localization and monitoring.

Aspartate Aminotransferase Mitochondrial Marker

Quantification of mitochondrial versus cytoplasmic AST isoforms to assess hepatocellular necrosis severity and apoptotic cell injury patterns.

Gamma-Glutamyl Transferase Hepatobiliary Disease

GGT isoenzyme profiling to differentiate cholestasis, hepatocellular damage, and alcoholic liver disease pathophysiology and disease progression.

Alkaline Phosphatase Bone Liver Isoform

Immunoassay-based separation of bone, liver, and intestinal alkaline phosphatase to identify organ-specific pathology and metabolic bone disease.

5-Nucleotidase Hepatic Cholestasis Specificity

5-nucleotidase measurement as highly specific marker for intrahepatic and extrahepatic cholestasis compared to alkaline phosphatase.

Tissue Plasminogen Activator Fibrinolytic Function

Functional assays measuring tissue plasminogen activator activity and antigen to assess endothelial fibrinolytic capacity in thrombotic disorders.

Plasminogen Activator Inhibitor Type One

Measurement of PAI-1 antigen and activity as hypercoagulability marker in metabolic syndrome, thrombosis, and cardiovascular disease.

Thrombin Antithrombin Complex Coagulation Activation

Quantification of TAT complexes in plasma as sensitive marker of in vivo thrombin generation and thrombotic disease activity.

Prothrombin Fragment One Two Thrombosis

Measurement of prothrombin fragment 1+2 to assess endogenous thrombin potential and thrombotic risk in coagulation disorders.

Fibrin Monomer Disseminated Intravascular Coagulation

Detection of fibrin monomers and fibrin degradation products for early DIC diagnosis and monitoring in critical illness.

Activated Partial Thromboplastin Time Mixing

Interpretive APTT mixing studies and factor assays to differentiate factor deficiencies, inhibitors, and lupus anticoagulant presence.

Antithrombin III Functional Activity Deficiency

Chromogenic and clotting-based antithrombin assays to diagnose type I and type II deficiencies predisposing to venous thromboembolism.

Protein C Anticoagulant Pathway Dysfunction

Functional and immunological protein C measurement for detecting deficiency states and predicting hypercoagulable thrombotic complications.

Protein S Free Circulating Anticoagulant

Total and free protein S quantification to diagnose hereditary and acquired deficiencies underlying familial thrombophilia.

Von Willebrand Factor Multimer Analysis

Agarose gel electrophoresis analysis of vWF multimers to classify von Willebrand disease types and predict bleeding severity.

Soluble Fibrin Polymer Thrombogenicity Marker

Quantification of soluble fibrin polymers as hypercoagulable state marker in disseminated cancer, sepsis, and thrombotic disorders.

Thromboelastography Platelet Function Viscoelasticity

Point-of-care viscoelastic testing providing comprehensive hemostasis assessment and personalized transfusion management in hemorrhagic states.

Platelet Aggregation Impedance Aggregometry

Whole blood impedance aggregometry evaluating platelet function response to multiple agonists for diagnosing platelet disorders and aspirin resistance.

Flow Cytometry Platelet Microparticles Thrombosis

Quantification of tissue factor-bearing microparticles and platelet-derived vesicles predicting thrombotic complications in cancer and sepsis.

Hemoglobin A1c Glycation Diabetes Control

High-performance liquid chromatography and immunoassay standardization of HbA1c for accurate long-term glycemic control assessment.

Glycated Albumin Short-Term Hyperglycemia

Measurement of glycated albumin reflecting two to three week glucose control for monitoring acute glycemic changes and pregnancy diabetes.

Fructosamine Intermediate Glycemic Marker

Quantification of fructosamine as two week glycemic control marker for assessing treatment efficacy and detecting medication non-adherence.

Continuous Glucose Monitoring Interstitial Glucose

Development of enzymatic glucose sensors and telemetry systems for real-time interstitial fluid glucose measurement in diabetes management.

Glucose Oxidase Enzyme Electrode Biosensor

Optimization of enzyme-based amperometric sensors using glucose oxidase and mediators for implantable continuous glucose monitoring devices.

Lactate Pyruvate Anaerobic Metabolism Shock

Point-of-care lactate and pyruvate measurements for assessing tissue hypoxia severity and predicting mortality in septic and cardiogenic shock.

Ketone Bodies Beta-Hydroxybutyrate Metabolism

Enzymatic and mass spectrometry measurement of beta-hydroxybutyrate and acetoacetate for diabetic ketoacidosis diagnosis and monitoring.

Ammonia Hepatic Encephalopathy Urea Cycle

Point-of-care and laboratory ammonia quantification using enzymatic assays for assessing hepatic dysfunction and neurological complications.

Bilirubin Unconjugated Conjugated Hepatic Function

High-performance liquid chromatography separation of bilirubin species to differentiate hepatic injury patterns and conjugation dysfunction.

Bile Acid Serum Concentration Hepatic Pathology

Measurement of total and individual bile acids reflecting enterohepatic circulation integrity and hepatic synthetic function impairment.

Cholesterol Ester Transfer Protein Activity

Functional assays measuring CETP activity to understand lipoprotein remodeling and evaluate therapeutic CETP inhibition in dyslipidemia.

Phospholipid Transfer Protein Lipoprotein Exchange

Measurement of phospholipid transfer protein activity affecting HDL and VLDL composition in dyslipidemia and cardiovascular disease.

Proprotein Convertase Subtilisin Kexin PCSK9

Quantification of PCSK9 protein regulating LDL receptor availability for understanding familial hypercholesterolemia and therapeutic targeting.

Small Dense LDL Particle Characterization

Ion mobility analysis and ultracentrifugation separation of atherogenic small dense LDL particles predicting cardiovascular event risk.

Oxidized LDL Autoantibody Immune Response

Measurement of oxidized LDL and anti-oxidized LDL antibodies reflecting atherosclerotic plaque inflammation and immune activation.

Lipoprotein a Apo B Containing Particles

Isoform-specific measurement of lipoprotein a as independent thrombotic and inflammatory cardiovascular risk factor.

Sphingolipid Profiling Lysosomal Storage Disorders

Investigation of ceramide and sphingosine metabolite patterns for diagnosis and monitoring of lysosomal storage diseases using tandem mass spectrometry.

Circulating Exosomal microRNA Cancer Detection

Analysis of tumor-derived exosomal microRNA cargo for early cancer detection and treatment response monitoring in liquid biopsies.

Glycated Albumin Hyperglycemia Control Assessment

Development of glycated albumin measurement methods as intermediate-term glycemic markers for diabetes management and complications risk stratification.

Acylcarnitine Panel Mitochondrial Dysfunction Screening

Comprehensive acylcarnitine profiling for diagnosis of metabolic disorders affecting fatty acid oxidation and mitochondrial energy metabolism.

Natriuretic Peptide Receptor Signaling Biomarkers

Study of mid-regional proANP and NT-proBNP fragments as improved cardiac dysfunction and renal disease progression indicators.

Oxidative Stress Marker Antioxidant Capacity

Integration of malondialdehyde, protein carbonyls, and thiol measurements with total antioxidant capacity for chronic disease assessment.

Circulating Fibrin Degradation Product Thromboinflammation

Analysis of D-dimer variants and fibrin monomer levels as indicators of coagulation activation and vascular inflammation severity.

Fructosamine Glycemic Variability Short-Term Control

Assessment of fructosamine as a two-week glucose control indicator for diabetes management and hypoglycemic event prediction.

Amino Acid Imbalance Hepatic Encephalopathy

Quantification of Fischer ratio and aromatic to branched-chain amino acid ratios for liver disease severity and neurological complications.

Lipoprotein-Associated Phospholipase A2 Cardiovascular Risk

Development of Lp-PLA2 activity assays as independent predictors of atherosclerotic cardiovascular disease and stroke risk.

Soluble P-Selectin Platelet Activation Assessment

Measurement of sP-selectin as a marker of in vivo platelet activation and thrombotic risk in cardiovascular pathology.

Urinary Albumin Creatinine Ratio Progression

Advanced HPLC and immunoturbidimetric methods for detecting early albuminuria and monitoring diabetic kidney disease progression.

Growth Differentiation Factor-15 Multi-Disease Prognosis

Investigation of GDF-15 as a universal risk marker for cardiovascular disease, cancer, and mortality across multiple pathologies.

Mycophenolic Acid Immunosuppressant Monitoring

Development of HPLC-MS assays for mycophenolic acid and metabolite quantification in transplant and autoimmune disease patients.

Soluble ST2 Cardiac Fibrosis Progression

Assessment of soluble suppression of tumorigenicity 2 as a marker of cardiac remodeling and heart failure prognosis.

Kynurenine Pathway Metabolite Immunomodulation

Analysis of kynurenine, tryptophan, and quinolinic acid levels for understanding immunosuppression and autoimmune disease mechanisms.

Pentraxin-3 Vascular Inflammation Endothelial Dysfunction

Development of assays measuring long pentraxin-3 as an early marker of vascular inflammation and atherosclerosis progression.

Asymmetric Dimethylarginine Endothelial Dysfunction

Measurement of ADMA as a marker of nitric oxide availability and vascular endothelial function in hypertension and renal disease.

Calprotectin Fecal Intestinal Inflammation

Optimization of immunoassay methods for measuring fecal calprotectin as non-invasive inflammatory bowel disease activity assessment.

Zonula Occludens-1 Intestinal Permeability Barrier

Investigation of circulating tight junction protein markers for quantifying intestinal barrier dysfunction in GI and systemic diseases.

Follicle-Stimulating Hormone Receptor Antibody Ovarian

Development of immunoassays detecting FSH receptor antibodies in premature ovarian failure and autoimmune ovarian disease.

Tissue Plasminogen Activator Fibrinolytic Capacity

Measurement of endogenous tPA and inhibitor ratios for assessing fibrinolytic potential and thrombotic risk stratification.

Phosphate Homeostasis Fibroblast Growth Factor 23

Analysis of FGF23 and Klotho protein interactions in chronic kidney disease and mineral bone disorder pathophysiology.

Prolactin-Inducible Protein Salivary Gland Dysfunction

Measurement of salivary PIP as a biomarker for Sjogren''s syndrome severity and salivary gland autoimmune destruction.

Endomysial Antibody Celiac Disease Serology

Development of high-specificity anti-endomysial antibody immunofluorescence assays for celiac disease diagnosis confirmation.

Prolactin Hyperprolactinemia Endocrine Evaluation

Optimization of prolactin immunoassays with macroprolactin detection for distinguishing physiologic and pathologic hyperprolactinemia.

Adrenocorticotropic Hormone Rhythm Circadian Dysfunction

Investigation of ACTH and cortisol diurnal rhythms as markers of hypothalamic-pituitary-adrenal axis dysfunction.

Creatine Kinase Isoenzyme Skeletal Muscle Damage

Analysis of CK-MB and CK-BB isoenzyme patterns for differential diagnosis of cardiac, skeletal, and neurological muscle injury.

Immunoglobulin G Subclass Immunodeficiency Profiling

Quantification of IgG1-IgG4 subclasses for assessing specific antibody deficiency and immune response competence.

Secretory Phospholipase A2 Inflammation Intensity

Measurement of sPLA2 isotypes as acute phase inflammatory markers and predictors of acute coronary syndrome.

Apolipoprotein B Particle Number Atherogenic Dyslipidemia

Quantification of ApoB as improved indicator of atherogenic particle burden compared to traditional lipid panels.

Serum Amyloid A Acute Phase Response

Development of high-sensitivity SAA assays for detecting systemic inflammation earlier than CRP in acute conditions.

Copper Ceruloplasmin Wilson Disease Diagnosis

Integration of serum copper, ceruloplasmin, and free copper measurements for improved Wilson disease detection and monitoring.

Progesterone Metabolite Luteal Phase Assessment

Analysis of pregnanediol and progesterone metabolites via GC-MS for confirming ovulation and luteal sufficiency.

Atrial Natriuretic Peptide Renal Function Correlation

Investigation of ANP and NT-ANP relationships with glomerular filtration and sodium handling in chronic kidney disease.

Von Willebrand Factor Platelet Function Thrombosis

Measurement of vWF antigen, activity, and ADAMTS13 ratio for assessing platelet dysfunction and prothrombotic states.

Monocyte Chemoattractant Protein-1 Atherosclerosis Progression

Quantification of MCP-1/CCL2 as marker of monocyte recruitment and atherosclerotic plaque inflammation.

Angiotensin-Converting Enzyme Activity Granulomatous Disease

Measurement of serum ACE activity for diagnosis and monitoring of sarcoidosis and other granulomatous diseases.

Beta-2 Microglobulin Renal Tubular Dysfunction

Quantification of serum and urinary B2M for assessing glomerular filtration and tubular reabsorption capacity.

Interleukin-6 Cytokine Storm Sepsis Monitoring

Real-time measurement of IL-6 kinetics for predicting sepsis severity, organ dysfunction, and treatment response.

Prealbumin Nutritional Status Short-Term Indicator

Development of immunoturbidimetric assays for transthyretin as rapid marker of protein malnutrition and metabolic stress.

Organ-Specific Autoantibody Profiling Autoimmune Hepatitis

Development of multiplex immunoassays detecting anti-LKM and anti-SLA antibodies for autoimmune liver disease classification.

Neopterin Immune Activation Cellular Immunodeficiency

Measurement of neopterin as marker of macrophage activation and cellular immune response intensity in infections.

Parathyroid Hormone-Related Peptide Hypercalcemia Etiology

Quantification of PTHrP for differentiating primary hyperparathyroidism from humoral hypercalcemia of malignancy.

Immunoglobulin A Tissue Transglutaminase Celiac Serology

Development of quantitative anti-tTG IgA assays with IgA deamidation epitope specificity for celiac disease screening.

Aromatase Activity Estrogen Biosynthesis Disorders

Investigation of estrone and estradiol production rates for assessing aromatase function in hormone-dependent malignancies.

High-Sensitivity C-Reactive Protein Subclinical Inflammation

Optimization of hsCRP measurement methodologies for improved cardiovascular risk stratification below conventional detection thresholds.

Myelin Basic Protein Demyelinating Disease Cerebrospinal Fluid

Analysis of CSF myelin basic protein and other myelin debris markers for assessing demyelinating disease activity.

Carcinoembryonic Antigen Heterogeneity Adenocarcinoma Subtyping

Investigation of CEA glycosylation variants and immunological forms for cancer type differentiation and prognosis assessment.

Glycated Hemoglobin Variants Diabetes Management

Characterization of HbA1c isoforms and non-enzymatic glycation patterns for improved glycemic control assessment in diverse patient populations.

Urinary Proteome Renal Disease Stratification

Mass spectrometry-based profiling of urine proteins to identify novel biomarkers for early detection and progression monitoring of nephropathies.

Serum Metabolite Fingerprinting Oncology Staging

High-resolution metabolomic analysis of circulating metabolites to establish tumor burden quantification and metastatic disease phenotyping.

Oxidative Stress Biomarker Panel Cardiovascular Risk

Multiplex measurement of reactive oxygen species scavenging capacity and lipid peroxidation products for atherosclerotic disease prediction.

Cardiac Fibrosis Marker Collagen Fragment Analysis

Detection of collagen turnover byproducts in serum to assess myocardial remodeling and predict heart failure progression trajectories.

Bacterial Sepsis Biomarker Acute Phase Response

Simultaneous quantification of multiple acute phase reactants and immune activation markers for rapid sepsis severity stratification.

Neurotrophic Factor Blood Brain Barrier Transport

Investigation of brain-derived neurotrophic factor and related neuropeptides as cerebrospinal fluid-accessible biomarkers in neuropsychiatric disorders.

Hepatic Fibrosis Staging Noninvasive Biomarkers

Integration of hyaluronic acid, procollagen peptides, and tissue inhibitor ratios to predict cirrhosis development and hepatic decompensation.

Extracellular DNA Neutrophil Extracellular Traps

Quantification of cell-free double-stranded DNA and associated histones as markers of neutrophil activation in systemic inflammation.

Insulin-Like Growth Factor Binding Protein Metabolism

Analysis of IGFBP-3 cleavage products and IGF axis dysregulation in endocrine malignancies and growth disorder diagnostics.

Thiamine Pyrophosphate Enzyme Activity Metabolism

Functional assessment of thiamine-dependent enzyme complexes through transketolase activity testing for nutritional status evaluation.

Soluble Interleukin Receptor Inflammatory Resolution

Measurement of circulating soluble IL-2R, IL-6R, and TNF receptors to distinguish acute inflammation from chronic immunological dysfunction.

Aromatase Activity Estrogen Biosynthesis Breast Cancer

Quantification of local estrogen production enzymes and circulating estrogen metabolites for endocrine therapy response prediction.

Ketone Body Metabolism Diabetic Ketoacidosis

Simultaneous measurement of beta-hydroxybutyrate, acetoacetate, and acetone to assess severity of metabolic derangement in diabetes.

Papain-Like Serum Protease Dysregulation Sepsis

Detection of elevated proteolytic enzyme activity and protease-antiprotease imbalance as indicators of systemic proteolysis during infection.

Circulating Immune Complex Deposition Vasculitis

Quantification of antigen-antibody aggregates and complement component binding in autoimmune vasculitic disease classification.

Albumin Fragmentation Liver Synthetic Function

Analysis of albumin cleavage products and N-terminal prealbumin for sensitive assessment of hepatic protein synthesis capacity.

Platelet Activation Marker Aggregometry Testing

Measurement of P-selectin expression, platelet microparticles, and thrombin-antithrombin complexes for thrombotic risk assessment.

Fructosamine Glycemic Control Intermediate Term

Quantification of glycated serum proteins as two to three week glucose control indicators for diabetes management optimization.

Endothelial Dysfunction Marker Nitric Oxide Bioavailability

Assessment of asymmetric dimethylarginine, L-arginine ratios, and endothelial progenitor cells for vascular dysfunction detection.

Adrenal Insufficiency Cortisol Metabolite Panel

Comprehensive measurement of plasma cortisol, free cortisol, and urinary metabolites to distinguish primary versus secondary adrenal failure.

Myocardial Infarction MicroRNA Diagnostic Signature

Profiling of cardiospecific microRNA species in blood to enable earlier detection and risk stratification of acute coronary syndrome.

Tissue Resident Marker Immune Cell Trafficking

Measurement of integrin expression patterns and chemokine receptor profiles to assess lymphocyte homing and tissue-specific inflammation.

Catecholamine Metabolite Neuroblastoma Detection Children

Quantification of plasma free metanephrines and urine vanillylmandelic acid for pediatric neuroendocrine tumor screening and surveillance.

Thyroglobulin Antibody Thyroid Cancer Surveillance

Detection of anti-thyroglobulin immunoglobulins to identify false-negative thyroglobulin measurements in differentiated thyroid carcinoma monitoring.

Lipoprotein Associated Phospholipase A2 Vascular Inflammation

Measurement of Lp-PLA2 activity and mass as independent atherosclerotic inflammation biomarker for cardiovascular event prediction.

Lipopolysaccharide Binding Protein Bacterial Translocation

Quantification of LBP as an indirect marker of gram-negative endotoxemia and intestinal barrier integrity in critical illness.

Soluble Urokinase Plasminogen Activator Receptor Inflammation

Detection of suPAR as a pan-inflammatory biomarker predicting organ dysfunction and mortality across heterogeneous patient populations.

Beta-Trace Protein Renal Filtration Capacity

Measurement of beta-2 microglobulin alternative markers for early glomerular filtration rate decline detection in preclinical kidney disease.

Parathyroid Hormone Secretion Dynamics Calcium Homeostasis

Time-resolved PTH and phosphate measurements to characterize abnormal feedback regulation in primary and secondary hyperparathyroidism.

Luteinizing Hormone Follicle Stimulating Hormone Ratio

Assessment of gonadotropin ratios and pulsatile secretion patterns for polycystic ovary syndrome and hypogonadism differentiation.

Angiotensin Converting Enzyme Isoform Activity Sarcoidosis

Measurement of serum ACE activity and isoforms to distinguish systemic sarcoidosis from other granulomatous disease processes.

Carbohydrate Antigen Tumor Associated Glycoprotein Panel

Multiplex carbohydrate antigen and tissue-associated glycoprotein measurement for cancer screening and recurrence detection optimization.

Prolactin Fragment Pituitary Prolactinoma Diagnosis

Detection of prolactin isoforms and fragments to improve diagnostic specificity in macroprolactinemia and pituitary adenoma evaluation.

Immunoglobulin M Rheumatoid Factor Seronegative Arthritis

Measurement of IgM-RF isotypes and anti-cyclic citrullinated peptide antibodies for early seropositive rheumatoid arthritis detection.

Ferritin Glycosylation Pattern Inflammation Acute Phase

Analysis of ferritin carbohydrate structure to distinguish iron overload from acute phase reaction-induced hyperferritinemia.

C-Reactive Protein High Sensitivity Microvascular Dysfunction

Ultra-sensitive hsCRP measurement integrated with inflammatory marker panels to assess subclinical atherosclerotic vascular inflammation.

Malondialdehyde Protein Adduct Oxidative Stress Diabetes

Quantification of lipid peroxidation end products and protein carbonylation as markers of chronic glycemic dyscontrol complications.

Prothrombin Fragment Activation Pathways Coagulation

Measurement of F1+2 fragments and thrombin generation assays to assess tissue factor and contact pathway activation intensity.

Enolase Neuron Specific Isozyme Neuronal Damage

Detection of neuron-specific enolase in cerebrospinal fluid and serum for traumatic brain injury and hypoxic encephalopathy assessment.

Glycine N-Methyltransferase Activity Hepatic Methionine Metabolism

Measurement of GNMT activity and S-adenosylmethionine ratios for hepatic synthetic dysfunction and cirrhosis severity grading.

Fibrinogen Fragment Fibrinolysis Plasmin Activity

Quantification of fibrin degradation products and D-dimer isoforms to distinguish primary from secondary fibrinolysis processes.

Asymmetric Dimethylarginine ADMA Renal Endothelial Dysfunction

Measurement of nitric oxide synthase inhibitor ADMA accumulation in chronic kidney disease and cardiovascular comorbidity prediction.

Interferon Gamma Release Assay Mycobacterial Immunity

Measurement of IFN-gamma response to mycobacterial antigens for tuberculosis infection differentiation and treatment monitoring.

Immunofixation Electrophoresis Monoclonal Protein Characterization

Comprehensive immunological characterization of serum and urine monoclonal proteins for plasma cell dyscrasia diagnosis and classification.

Von Willebrand Factor Antigen Activity Shear Stress

Simultaneous measurement of vWF:Ag, vWF:RCo activity, and ADAMTS13 cleavage capacity for hemostatic disorder characterization.

Bilirubin Glucuronide Conjugation Hepatic Phase II Metabolism

Assessment of unconjugated versus conjugated bilirubin ratios and urobilinogen patterns for cholestasis versus hemolysis differentiation.

Transthyretin Amyloid Protein Misfold Detection

Detection of amyloidogenic transthyretin variants and wild-type protein oligomers for hereditary and senile transthyretin amyloidosis diagnosis.

Extracellular RNA Stability Biofluid Diagnostics

Investigation of circulating RNA degradation kinetics and stabilization mechanisms in blood and body fluids for improved disease detection and prognostic accuracy.

Pregnancy-Associated Plasma Protein A Placental Function

Serial measurement of PAPP-A levels throughout pregnancy for fetal aneuploidy risk assessment and placental insufficiency prediction.

Organophosphate Pesticide Metabolite Exposure Biomonitoring

Development of high-resolution mass spectrometry methods to quantify urinary and serum pesticide metabolites for environmental health risk assessment and occupational exposure surveillance.